- Home
- KZIA vs HIHO Comparison
KZIA vs HIHO Comparison
Compare KZIA & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- HIHO
- Stock Information
- Founded
- KZIA 1994
- HIHO 1990
- Country
- KZIA Australia
- HIHO Hong Kong
- Employees
- KZIA N/A
- HIHO N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- HIHO Industrial Machinery/Components
- Sector
- KZIA Health Care
- HIHO Industrials
- Exchange
- KZIA Nasdaq
- HIHO Nasdaq
- Market Cap
- KZIA 5.1M
- HIHO 7.2M
- IPO Year
- KZIA 1999
- HIHO 1996
- Fundamental
- Price
- KZIA $10.45
- HIHO $1.63
- Analyst Decision
- KZIA Strong Buy
- HIHO
- Analyst Count
- KZIA 2
- HIHO 0
- Target Price
- KZIA $14.00
- HIHO N/A
- AVG Volume (30 Days)
- KZIA 745.7K
- HIHO 7.8K
- Earning Date
- KZIA 07-22-2025
- HIHO 07-31-2025
- Dividend Yield
- KZIA N/A
- HIHO 7.32%
- EPS Growth
- KZIA N/A
- HIHO N/A
- EPS
- KZIA N/A
- HIHO 0.02
- Revenue
- KZIA $1,549,158.00
- HIHO $7,412,000.00
- Revenue This Year
- KZIA N/A
- HIHO N/A
- Revenue Next Year
- KZIA N/A
- HIHO N/A
- P/E Ratio
- KZIA N/A
- HIHO $82.00
- Revenue Growth
- KZIA 248983.08
- HIHO 17.26
- 52 Week Low
- KZIA $2.86
- HIHO $1.40
- 52 Week High
- KZIA $79.00
- HIHO $2.88
- Technical
- Relative Strength Index (RSI)
- KZIA 72.75
- HIHO 38.43
- Support Level
- KZIA $5.86
- HIHO $1.55
- Resistance Level
- KZIA $7.20
- HIHO $1.69
- Average True Range (ATR)
- KZIA 1.17
- HIHO 0.05
- MACD
- KZIA 0.15
- HIHO -0.01
- Stochastic Oscillator
- KZIA 82.21
- HIHO 36.36
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.